{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:58Z","timestamp":1793059978746,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.579606","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:12:21Z","timestamp":1603757541000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas"],"prefix":"10.3389","volume":"11","author":[{"given":"Jos\u00e9 Miguel","family":"Hinojosa-Amaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gonz\u00e1lez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Varlamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine G.","family":"Yedinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"New Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Investig."},{"key":"B4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fendo.2018.00768","article-title":"The mechanism and pathways of dopamine and dopamine agonists in prolactinomas","volume":"9","author":"Liu","year":"2019","journal-title":"Front Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11102-018-0898-y","article-title":"Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study","volume":"21","author":"Liu","year":"2018","journal-title":"Pituitary."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","article-title":"Prolactinomas","volume":"362","author":"Klibanski","year":"2010","journal-title":"New Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-18-0682","article-title":"Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas","volume":"180","author":"Ioachimescu","year":"2019","journal-title":"Eur J Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11102-011-0318-z","article-title":"Improvement of cardiac parameters in patients with acromegaly treated with medical therapies","volume":"15","author":"Colao","year":"2011","journal-title":"Pituitary."},{"key":"B9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40265-019-01128-7","article-title":"Medical management of cushing's syndrome: current and emerging treatments","volume":"79","author":"Hinojosa-Amaya","year":"2019","journal-title":"Drugs."},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","volume":"41","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Safety."},{"key":"B11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/ajp.156.2.181","article-title":"Toward a clinical model of suicidal behavior in psychiatric patients","volume":"156","author":"Mann","year":"1999","journal-title":"Am J Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12020-018-1744-8","article-title":"Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up","volume":"62","author":"Celik","year":"2018","journal-title":"Endocrine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Int Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1176\/appi.ps.201500149","article-title":"Does suicidal ideation as measured by the PHQ-9 predict suicide among VA patients?","volume":"67","author":"Louzon","year":"2016","journal-title":"Psychiatr Serv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1530\/EJE-18-0667","article-title":"Management Of Endocrine Disease: Impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry?","volume":"179","author":"Barake","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1210\/jc.2018-02202","article-title":"Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study","volume":"104","author":"Dogansen","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0924-9338(11)73438-1","article-title":"Impulsivity in pathological gambling","volume":"26","author":"Marazziti","year":"2011","journal-title":"Eur Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of medically refractory prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J Neurooncol."},{"key":"B19","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","article-title":"Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas","volume":"34","author":"Martinkova","year":"2011","journal-title":"Clin Neuropharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","article-title":"Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study","volume":"80","author":"Bancos","year":"2014","journal-title":"Clin Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors","volume":"105","author":"De Sousa","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and statistical manual of mental disorders","year":"2013","journal-title":"Am Psychiatr Assoc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/24750573.2017.1410329","article-title":"Singing under the impulsiveness: impulsivity in psychiatric disorders","volume":"28","author":"Kulacaoglu","year":"2017","journal-title":"Psychiatr Clin Psychopharmacol."},{"key":"B26","unstructured":"ClarkL From Impulsivity to Addiction: Gambling Disorder and Beyond2015"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e20428","DOI":"10.5812\/ijhrba.20428","article-title":"Impulsivity: a predisposition toward risky behaviors","volume":"3","author":"Bakhshani","year":"2014","journal-title":"Int J High Risk Behav Addict."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.psc.2018.10.011","article-title":"Binge-eating disorder","volume":"42","author":"Hilbert","year":"2019","journal-title":"Psychiatr Clin N Am."},{"key":"B29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.paid.2007.01.015","article-title":"The construct of impulsivity revisited","volume":"43","author":"Leshem","year":"2007","journal-title":"Person Indiv Differ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","article-title":"Minnesota impulse disorders interview (MIDI): validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample","volume":"265","author":"Chamberlain","year":"2018","journal-title":"Psychiatry Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781118625392.wbecp351","article-title":"Structured clinical interview for theDSM(SCID). In: Cautin RL and Lilienfeld SO, editors","author":"First","year":"2015","journal-title":"The Encyclopedia of Clinical Psychology"},{"key":"B32","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/001316448904900315","article-title":"A five-item measure of socially desirable response set","volume":"49","author":"Hays","year":"1989","journal-title":"Educ Psychol Meas."},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1556\/JBA.1.2012.001","article-title":"Psychometric development of the hypersexual behavior consequences scale","volume":"1","author":"Reid","year":"2012","journal-title":"J Behav Addict."},{"key":"B36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/00224499.2018.1494262","article-title":"The psychometric properties of the hypersexual behavior inventory using a large-scale nonclinical sample","volume":"56","author":"Bothe","year":"2018","journal-title":"J Sex Res."},{"key":"B37","unstructured":"Depression and Other Common Mental Disorders Global Health Estimates2017"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9781615371990","article-title":"The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry","author":"Levenson","year":"2018"},{"key":"B39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1037\/0735-7028.38.3.290","article-title":"The economics of behavioral health services in medical settings: A summary of the evidence","volume":"38","author":"Blount","year":"2007","journal-title":"Prof Psychol Res Pract."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/1475-6773.01086","article-title":"The effects of primary care depression treatment on patients' clinical status and employment","volume":"37","author":"Schoenbaum","year":"2002","journal-title":"Health Serv Res."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.579606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:46:36Z","timestamp":1669308396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.579606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":41,"alternative-id":["10.3389\/fendo.2020.579606"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.579606","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"article-number":"579606"}}